collagène hydrolysé
Food supplement declared in France, decision dated 6 November 2026
collagène hydrolysé (kinea) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- kinea
- Food business operator placing the product on the market
- DAVID GAILLARD
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 3g
- Directions for use
- Déconseillé aux femmes enceintes ou allaitantes sans avis médical. En cas de traitement en cours ou d'insuffisance rénale, demandez l'avis de votre médecin ou de votre pharmacien avant de commencer.
- Intended populations
- General population, Men and women aged 18 and over, People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, History of breast cancer, Kidney stones, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney failure, Kidney disease, Infants (under 1 year), Concurrent contraceptive use, Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Bones, Antioxidant, Joints
- Flavourings
- fruits rouges
Declaration 380639, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Substances
| Name | Per day |
|---|---|
| Chlorophylline de cuivre sodique | 0.3 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Collagène hydrolysé | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Bisglycinate de magnésium | Magnésium | 250 mg | 300 mg |
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas se substituer à une alimentation variée et équilibrée ni à un mode de vie sain. Tenir hors de portée des jeunes enfants.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Collagène hydrolysé
Read the warning, when it applies and the studies cited
Hydrolyzed Collagen
Route of administration: Oral
Cautions and warnings
Condition of application: Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Applies to products providing more than 2.8 g hydrolyzed collagen, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).
Sources cited by Health Canada (2)
- Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.
- Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease, 10th edition. Philadelphia (PA): Lippincott Williams and Wilkins, 2006.
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).
Sources cited by Health Canada (1)
- Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism 2000;30(2):87-99. PubMed Randomised trial
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : kinea
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.